Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-30

Clinical Trial Update: A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder [Phase 2]

View source ↗

Summary

Phase 2 randomized, placebo-controlled trial evaluating stellate ganglion block for post-traumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: United States Naval Medical Center, San Diego | Conditions: Post Traumatic Stress Disorder (PTSD) | Phase 2 | Status: COMPLETED